Tula, Russian Federation
Tula, Tula, Russian Federation
Osteoarthritis (OA) is the most common joint disease with high comorbidity. Among comorbid diseases in patients with OA, diseases of the cardiovascular system are in the first place. It is known that comorbid diseases mutually aggravate the course of each of the existing nosologies.It is important to study the impact of concomitant diseases in patients with OA on the quality and duration of life, to analyze the factors that contribute to an increased risk of cardiovascular disasters in patients with degenerative and destructive joint diseases.
Osteoarthritis, comorbidity, nonsteroidal anti-inflammatory drugs, cardiovascular diseases.
1. Revmatologiya: nacional'noe rukovodstvo. Pod red. E.L. Nasonova, V.A. Nasonovoy. M.: GEOTAR-Media, 2008;573-88.
2. Hedbom E., Huselmann H.J. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002;59:45-53.
3. Pickvance E.A., Oegema T.R.Jr., Thompson R.C. Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading. J Orthop Res 1993;113:313-23.
4. Agarwal S., Long P., Seyedain A. et al. A central role for the nuclear factor-kB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. FASEB J 2003;17:899-901.
5. Nasonov E.L., Karateev A.E. Primenenie nesteroidnyh protivovospalitel'nyh preparatov. Klinicheskie rekomendacii. RMZh 2006;14(25):1769-77.
6. Badokin V.V. Nesteroidnye protivovospalitel'nye preparaty v praktike vracha polikliniki: klinicheskaya farmakologiya ketoprofena. Consilium medicum. 2007; 5(4): 108-113.
7. Karpov Yu.A., Kulikova T.Yu. Nesteroidnye protivovospalitel'nye preparaty: voprosy serdechnososudistoy bezopasnosti. Aktual'nye voprosy bolezney serdca i sosudov. 2010; 4: 60-65.
8. Chichasova N.V. Problema boli pri osteoartroze. Lechaschiy vrach. 2007; 2: 45-49
9. Schaeverbeke T., Heloire F., Deray G. How to watch over a patient treated with NSAID in relation to the cardiovascular and renal risk. Press Med. 2006; 35(99): 41-46.
10. Kadam U.T. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales / U.T. Kadam, K. Jordan, P.R. Croft // Ann Rheum Dis. - 2004. - Vol. 63. 408-414.
11. Comorbid Conditions in the AMICA Study Patients: Effects on the Quality of Life and Drug Prescriptions by General Practitioners and Specialists. / Caporali R. [et al.] // Sem Arthr Rheum. - 2005. - Vol. 35. - Issue 1. - Suppl. 1. - P. 31-37.
12. Comorbidity of chronic diseases in general practice / Schellevis FG [et al.] // J Clin Epidemiol. - 1993.-Vol. 46.-№5.-P. 469-473.
13. Osteoartroz v praktike vracha terapevta / L.I. Alekseeva [i dr.] // RMZh. -2008. - T.16, №7. - S.476.
14. Dandona P, Aljada A, Chaudhury A, et al. Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation. Circulation 2005; 111: 1448-54.
15. Metabolicheskiy sindrom. Pod red. chl.-korr. RAMN G.E.Roytberga. Moskva “MED-press-inform” 2007; 83-103.
16. Aspden RM, Scheven BA, Hutchison JD. Osteoarthritis as a systemic desorder including stromal cell differentiation and lipid metabolism. Lancet 2001; 7; 357 (9262): 1118-20.
17. Monson R.R. Mortality among arthritics / R.R. Monson, A.P. Hall // J Chron Dis. - 1976. -Vol. 29. - P. 459-467.
18. Kellgren J.H. Radiographic assessment of osteoarthritis / J.H. Kellgren, Lawrence J.S. // Ann. Rheum. Dis. - 1957.-№ 16.-P. 494-501.
19. Osteoarthritis of finger joints in Finns ages 30 or over prevalence, determinants, and association with mortality / Haara [et al.] // Ann Rheum Dis.-2003.-Vol. 62. P. 151-158.
20. Hochberg M.C. Mortality in osteoarthritis / M.C. Hochberg // Clin Exp Rheumat.- 2008.-Vol. 26.-№ 5. - Suppl 51. - P. 120-124.
21. Osteoartroz kak faktor riska kardiovaskulyarnyh katastrof / O.I. Mendel' [i dr.] // RMZh, Nevrologiya 2007. - Tom 15, № 23. -S. 1 -5.
22. Mazurov V.I. Bolezni sustavov / V.I. Mazurov, V.A. Onuschenko, A.M. Lila // Rukovodstvo dlya vrachey. - SPB., 2008. - S.247-281.
23. Nasonov E.J1. Kardiovaskulyarnye problemy v revmatologii / E.L. Nasonov, T.V. Popkova // Nauchno-prakticheskaya revmatologiya - 2004. -№4.- S. 4-9.
24. Pobegay O.I. Osobennosti techeniya AG u bol'nyh OA avtoref. diss. ... k.m.n. - / Pobegay O.I. // S.-Peterburg. - 2010.
25. Comorbidities in patients with osteoarthritis: frequency and impact on pain and physical function / AA Leite [et al.] // Rev Bras Reumatol. - 2011 Apr. -Vol. 51,№2.-P. 118-23.
26. Egorov I.V Osobennosti lecheniya sustavnogo sindroma u lic pozhilogo vozrasta s arterial'noy gipertenziey / I.V. Egorov, V.V. Curko // Sovremennaya revmatologiya. - 2008. - №4. - S. 52.
27. Johnson A., Nguyen T., Day R. Do nonsteroidal anti-inflammatory drugs affect blood pressure? Ann Intern Med 1994;121:289-300.
28. Sowers J.R., White W.B., Pitt B. et al.; Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators. The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med 2005;165(2):161-8.
29. Schwartz J.I., Thach C., Lasseter K.C. et al. Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. J Clin Pharmacol 2007;47(12):1521-31.
30. Anichkov D.A., Shostak N.A. Sutochnyy profil' arterial'nogo davleniya u bol'nyh metabolicheskim sindromom i osteoartrozom na fone terapii nesteroidnymi protivovospalitel'nymi preparatami. Klin med 2004;82(12):27-30.
31. Reitblat T., Zamir D., Estis L. et al. The different patterns of blood pressure elevation by rofecoxib and nabumetone. J Hum Hypertens 2002;16:431-4.
32. Mukherjee D. Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? Congest Heart Fail 2008; 14(2):75-82.
33. Patrignani P., Capone M.L., Tacconelli S. NSAIDs and cardiovascular disease. Heart 2008;94(4):395-7.
34. Antman E.M., Bennett J.S., Daugherty A. et al; American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115(12):1634-42.
35. Alekseeva L.I. Mnogocentrovoe slepoe randomizirovannoe placebokontroliruemoe issledovanie simptom i strukturno-modificiruyuschego deystviya preparata alflutop u bol'nyh osteoartrozom kolennyh sustavov. / L.I. Alekseeva, E.L. Sharapova // Nauchno-prakticheskaya revmatologiya. - 2013. - №5. - S. 532-538.
36. Alekseeva L.I. Sovremennye podhody k lecheniyu osteoartroza. / L-1<1. Alekseeva // Russkiy medicinskiy zhurnal. - 2003. - № 11 (4). - S. 201-205.
37. Rossiyskie klinicheskie rekomendacii. Revmatologiya./ pod red.E.L.Nasonova. - M.: GEOTAR-Media, 2017. - 464 s.
38. Vedenie bol'nyh s osteoartritom i komorbidnost'yu v obschey vrachebnoy praktike. Klinicheskie rekomendacii. - Naumov A.V. i dr, - M., 2017. - 40 s.
